Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995 Nov 21;92(24):11259-63.
doi: 10.1073/pnas.92.24.11259.

Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination

Affiliations

Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination

D C Scherer et al. Proc Natl Acad Sci U S A. .

Abstract

The inhibitor protein I kappa B alpha controls the nuclear import of the transcription factor NF-kappa B. The inhibitory activity of I kappa B alpha is regulated from the cytoplasmic compartment by signal-induced proteolysis. Previous studies have shown that signal-dependent phosphorylation of serine residues 32 and 36 targets I kappa B alpha to the ubiquitin-proteasome pathway. Here we provide evidence that lysine residues 21 and 22 serve as the primary sites for signal-induced ubiquitination of I kappa B alpha. Conservative Lys-->Arg substitutions at both Lys-21 and Lys-22 produce dominant-negative mutants of I kappa B alpha in vivo. These constitutive inhibitors are appropriately phosphorylated but fail to release NF-kappa B in response to multiple inducers, including viral proteins, cytokines, and agents that mimic antigenic stimulation through the T-cell receptor. Moreover, these Lys-->Arg mutations prevent signal-dependent degradation of I kappa B alpha in vivo and ubiquitin conjugation in vitro. We conclude that site-specific ubiquitination of phosphorylated I kappa B alpha at Lys-21 and/or Lys-22 is an obligatory step in the activation of NF-kappa B.

PubMed Disclaimer

References

    1. Annu Rev Immunol. 1994;12:141-79 - PubMed
    1. Trends Genet. 1993 Dec;9(12):427-33 - PubMed
    1. Cell. 1994 Sep 9;78(5):787-98 - PubMed
    1. Cell. 1994 Oct 7;79(1):13-21 - PubMed
    1. J Exp Med. 1994 Oct 1;180(4):1321-8 - PubMed

Publication types

MeSH terms

LinkOut - more resources